23andMe is low on cash and its stock is worth pennies. The CEO wants another chance | CNN Business
Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Main Street. Today, the company is struggling to remain listed on the Nasdaq.
I don't think they got enough. They still have user studies, but now no one is willing to answer their questions. The results are behind paywall!